Movement Alert｜GENSCRIPT B-1K Intraday Rise 5.92% in Regular Trading, Institutional Accumulation Supports Sentiment

Market Focus10-21

On October 21, GENSCRIPT B-1K rose 5.92% in Regular Trading, trading at HK$35.64, with turnover of HK$87.69 million.

The move coincided with fresh disclosure of continued institutional accumulation. Pandanus Partners L.P. increased its stake by 10.552 million shares on October 13 at an average price of HK$35.9824 per share, involving about HK$380 million.

This followed another sizable purchase by FMR LLC, which bought 10.3699 million shares on October 12 at HK$42.0590 per share for about HK$436 million. FMR LLC had also added positions on September 24 and October 2, lifting its stake to about 166 million shares, or 7.26%.

Fundamentally, the company also disclosed that associate Legend Biotech’s core product CARVYKTI generated trade net sales of about US$710 million for the quarter ended September 30, reinforcing attention on its cell therapy and life sciences services businesses.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment